Cerecor Inc. (CERC) financial statements (2020 and earlier)

Company profile

Business Address 540 GAITHER ROAD
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5112521
Cash and cash equivalents5112521
Restricted cash and investments00000
Receivables   0 
Inventory, net of allowances, customer advances and progress billings010  
Inventory010  
Other undisclosed current assets710800
Total current assets:132211622
Noncurrent Assets
Property, plant and equipment11000
Intangible assets, net (including goodwill)434832  
Goodwill161614  
Intangible assets, net (excluding goodwill)273118  
Restricted cash and investments0000 
Total noncurrent assets:45483200
TOTAL ASSETS:577043622
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46512
Accounts payable11111
Accrued liabilities00   
Employee-related liabilities22101
Taxes payable122  
Interest and dividends payable   00
Debt11 23
Business combination, contingent consideration, liability12   
Other undisclosed current liabilities1118601
Total current liabilities:17261146
Noncurrent Liabilities
Long-term debt and lease obligation1414  2
Long-term debt, excluding current maturities1414  2
Liabilities, other than long-term debt77310
Deferred income tax liabilities0
Other liabilities10010
Business combination, contingent consideration, liability673  
Other undisclosed noncurrent liabilities 11  
Total noncurrent liabilities:2223413
Total liabilities:39491569
Stockholders' equity
Stockholders' equity attributable to parent, including:182128013
Preferred stock00   
Common stock00000
Additional paid in capital134119837067
Accumulated deficit(116)(98)(58)(70)(54)
Other undisclosed stockholders' equity attributable to parent  3  
Total stockholders' equity:182128013
TOTAL LIABILITIES AND EQUITY:577043622

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2018281 
Revenue, net281 
Cost of revenue
(Cost of Goods and Services Sold)
(5)(7)(0)  
Gross profit:1511281 
Operating expenses(43)(58)(14)(17)(11)
Other undisclosed operating income570  
Operating income (loss):(23)(39)14(16)(11)
Nonoperating income (expense)(0)(1)(0)(0)1
Income (loss) from continuing operations before income taxes:(23)(40)14(16)(10)
Income tax expense (benefit)(0)0(2)  
Net income (loss) attributable to parent:(23)(40)12(16)(10)
Other undisclosed net loss available to common stockholders, basic(2)(2)(4)  
Net income (loss) available to common stockholders, basic:(25)(42)8(16)(10)
Other undisclosed net income available to common stockholders, diluted  0  
Net income (loss) available to common stockholders, diluted:(25)(42)8(16)(10)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(23)(40)12(16)(10)
Comprehensive income (loss), net of tax, attributable to parent:(23)(40)12(16)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: